Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

LICATA, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.581
EU - Europa 9.000
AS - Asia 7.410
SA - Sud America 1.114
Continente sconosciuto - Info sul continente non disponibili 1.094
AF - Africa 265
OC - Oceania 28
Totale 36.492
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.220
SG - Singapore 2.525
IT - Italia 2.507
RU - Federazione Russa 2.443
CN - Cina 1.962
HK - Hong Kong 893
FI - Finlandia 881
BR - Brasile 864
DE - Germania 684
VN - Vietnam 644
PL - Polonia 441
UA - Ucraina 371
GB - Regno Unito 359
FR - Francia 345
IE - Irlanda 342
BD - Bangladesh 283
JP - Giappone 205
IN - India 199
CA - Canada 182
SE - Svezia 159
KR - Corea 155
NL - Olanda 107
TR - Turchia 96
MX - Messico 94
RO - Romania 67
AR - Argentina 65
ES - Italia 60
AT - Austria 58
IQ - Iraq 55
ZA - Sudafrica 53
MA - Marocco 50
BE - Belgio 44
ID - Indonesia 42
CL - Cile 38
PK - Pakistan 37
UZ - Uzbekistan 37
EC - Ecuador 36
VE - Venezuela 33
CI - Costa d'Avorio 32
IR - Iran 30
KE - Kenya 27
EG - Egitto 26
AZ - Azerbaigian 25
PH - Filippine 24
CO - Colombia 23
CZ - Repubblica Ceca 23
MY - Malesia 23
DZ - Algeria 22
NP - Nepal 22
AE - Emirati Arabi Uniti 21
SA - Arabia Saudita 21
AU - Australia 19
JM - Giamaica 18
JO - Giordania 17
PY - Paraguay 16
BG - Bulgaria 15
PE - Perù 15
KZ - Kazakistan 14
CH - Svizzera 13
BO - Bolivia 12
EU - Europa 12
HN - Honduras 12
TH - Thailandia 12
ET - Etiopia 11
LB - Libano 11
TN - Tunisia 11
LT - Lituania 10
NZ - Nuova Zelanda 9
PT - Portogallo 9
RS - Serbia 9
AL - Albania 8
CR - Costa Rica 8
PA - Panama 8
TW - Taiwan 8
UY - Uruguay 8
BB - Barbados 7
GT - Guatemala 7
QA - Qatar 7
SN - Senegal 7
BH - Bahrain 6
DO - Repubblica Dominicana 6
GR - Grecia 6
HU - Ungheria 6
AO - Angola 5
DK - Danimarca 5
EE - Estonia 5
IL - Israele 5
SI - Slovenia 5
AM - Armenia 4
BN - Brunei Darussalam 4
BY - Bielorussia 4
NI - Nicaragua 4
PS - Palestinian Territory 4
SV - El Salvador 4
TG - Togo 4
XK - ???statistics.table.value.countryCode.XK??? 4
CY - Cipro 3
GA - Gabon 3
GE - Georgia 3
GY - Guiana 3
Totale 35.361
Salva come PNG Salva come JPEG
Città #
Ashburn 2.094
Fairfield 2.049
Singapore 1.710
San Jose 1.128
Chandler 1.009
Woodbridge 951
Seattle 803
Houston 788
Wilmington 781
Cambridge 687
Hong Kong 663
Ann Arbor 500
Palermo 421
Council Bluffs 389
Zgierz 384
Dublin 341
Beijing 336
Moscow 336
Los Angeles 289
Medford 269
New York 254
Helsinki 232
Des Moines 231
Ho Chi Minh City 230
Altamura 210
Santa Clara 209
Nanjing 195
Tokyo 178
Jacksonville 174
Princeton 173
Lauterbourg 171
Boardman 167
Hanoi 160
The Dalles 159
Milan 152
Lawrence 150
Frankfurt am Main 145
Dallas 135
San Diego 135
Dearborn 106
Hefei 103
Rome 102
Jinan 91
Buffalo 88
Chicago 87
São Paulo 80
Tulsa 75
Nanchang 73
Phoenix 72
Shenyang 71
London 68
Nuremberg 68
Orem 63
Tianjin 59
Changsha 55
Ludwigshafen am Rhein 55
Hebei 53
Columbus 50
Munich 49
Izmir 47
Naples 47
Amsterdam 45
Guangzhou 44
Brussels 42
Toronto 42
Atlanta 41
Ningbo 41
Jiaxing 40
Mumbai 39
Warsaw 39
Zhengzhou 37
Chennai 36
Redwood City 35
Falls Church 33
Abidjan 32
Da Nang 32
Montreal 31
Vienna 31
Johannesburg 30
Springfield 30
Brooklyn 29
Denver 29
Casablanca 28
Kumar 27
Manchester 27
San Paolo di Civitate 27
Florence 26
Haiphong 26
Seongnam 26
Bremen 25
Verona 25
Hangzhou 24
Mexico City 24
Poplar 24
Saint Petersburg 24
Lappeenranta 23
Nairobi 23
Rio de Janeiro 23
Stockholm 23
Taizhou 23
Totale 22.156
Salva come PNG Salva come JPEG
Nome #
MODIFICAZIONI ECOGRAFICHE DELLA LINFADENOPATIA DELL’ILO EPATICO DOPO ERADICAZIONE DELL’HCV CON DIRECT-ACTING ANTIVIRALS 561
PRESENTAZIONE ECOGRAFICA DELL’EPATOCARCINOMA: ESPERIENZA DI UN SINGOLO CENTRO NELL’ARCO DI TRE DECENNI 415
A phenobarbital overdose: a case report 405
Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis 399
Clinical manifestations and outcome predictors of SARS-COV2 disease (COVID-19): experience of a single center. 395
Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b 335
HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals 333
Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study. 311
Clinical course and management of acute and chronic viral hepatitis during pregnancy. 306
The presence of white matter lesions is associated with the fibrosis severity of nonalcoholic fatty liver disease 306
Clinical course and genetic susceptibility of primary biliary cirrhosis: Analysis of a prospective cohort 302
Early carotid atherosclerosis and cardiac diastolic abnormalities in hypertensive subjects 298
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 280
Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease 277
Clinical course and outcomes of drug-induced liver injury: Nimesulide as the first implicated medication. 276
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology 276
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 275
EFFETTI DELLA TERAPIA CON DIRECT ACTING ANTIVIRALS (DAAS) SUI PARAMETRI ECOGRAFICI DI IPERTENSIONE PORTALE 268
Surveillance program for diagnosis of hcc in liver cirrhosis: Role of ultrasound echo patterns 264
751 RETINOL-BINDING PROTEIN 4 (RBP4): A NEW MARKER OF G1 HCV-INDUCED STEATOSIS 263
Clinical implications of the hyperdynamic syndrome in cirrhosis. 263
Expression of cytokeratin 7 and 20 in pathological conditions of the bile tract 262
PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease 257
Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: A retrospective cohort study. 254
Elderly Onset Celiac Disease: A Narrative Review. 254
C4BQ0: a genetic marker of familial HCV-related liver cirrhosis. 252
Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 251
Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study 251
Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations. 249
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 248
Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection 246
Can chemotherapy concomitantly delivered with radiotherapy improve survival of patients with resectable rectal cancer? A meta-analysis of literature data 245
The course of oesophagogastric varices in patients with cirrhosis after DAA-induced HCV clearance 245
Clinical trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites. 243
Nontumorous portal vein thrombosis in liver cirrhosis: Possible role of β-blockers 243
Acute hepatitis C: in search of the optimal approach to cure. 242
Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems 241
Rivaroxaban-induced hepatotoxicity: review of the literature and report of new cases 236
A patient with acute hepatitis C and possible IFN toxicity [2] 232
Retinol-binding protein 4 (RBP4) : a new marker of G1 HCV-induced steatosis 231
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study 231
Inflammation and Aortic Stiffness: An Individual Participant Data Meta-Analysis in Patients With Inflammatory Bowel Disease. 231
Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease 230
Imaging features of pancreatic metastases: A comparison with pancreatic ductal adenocarcinoma 230
The Changing Epidemiology of Hepatocellular Carcinoma :  Experience of a Single Center 229
Serology in adults with celiac disease: limited accuracy in patients with mild histological lesions. 228
Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis 226
Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study 226
Plasma adiponectin: A contributing factor for cardiac changes in visceral obesity-associated hypertension 223
Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis C virus genotype 1. 221
Genetic predisposition to thrombophilia in inflammatory bowel disease 221
Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma. 220
Relationship between circulating E-selectin, DD genotype of angiotensin-converting-enzyme, and cardiovascular damage in central obese subjects 220
A woman with a long history of abdominal pain 219
The impact of radiotherapy on survival in resectable gastric carcinoma: A meta-analysis of literature data. 218
Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort 218
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program 214
A Case of Fatal Drug Rash Eosinophilia and Systemic Symptoms from Allopurinol 213
Cardiac involvement in rheumatoid arthritis: evidence of silent heart disease 209
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 209
Serum BLYS/BAFF levels in acute hepatitis C predict clinical outcome 208
Case report: acute portal vein thrombosis associated with acute cytomegalovirus infection in an immunocompetent adult 208
DRUG INDUCED LIVER INJURIES BY TICAGRELORSTATINS INTERACTION: A CASE REPORT 208
Epidemiology, Diagnosis, and Non-Pharmacological Treatment of HCC 205
Renal function is impaired in normotensive chronic HCV patients: role of insulin resistance 205
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 205
Is vitamin D deficiency predictor of complications development in patients with HCV-related cirrhosis? 203
Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies 202
Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease 201
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 201
Competing risks and prognostic stages of cirrhosis: A 25-year inception cohort study of 494 patients 199
AISF position paper on liver disease and pregnancy. 199
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents 199
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? the REAL Experience 199
Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: A meta-analysis. 198
Lymphocyte beta-adrenergic receptors in young subjects with peripheral or central obesity: relationship with central haemodynamics and left ventricular function 198
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. 197
Mortality in patients with hepatocellular carcinoma predicted by six scoring: none is the winner 196
Effetti cardioprotettivi del Blocco del Sistema Renina-Angiotensina-Aldosterone tramite l’associazione ACE-inibitore – Sartani: Relazione con i livelli circolanti di Transforming Growth Factor ß1. 196
COMEPA (COVID-19 Medicina Policlinico Palermo): a study in hospitalized patients. 195
Treatment of hepatitis C: critical appraisal of the evidence 194
Radio-frequency thermal ablation (RFTA) of small hepatocellular carcinoma in patients with cirrhosis. Experience at a single tertiary referral center 194
When and how to treat acute hepatitis C? 194
CLINICAL COURSE OF NIMESULIDE-INDUCED LIVER INJURY 192
Prognostic indicators of successful endoscopic sclerotherapy for prevention of rebleeding from oesophageal varices in cirrhosis: a long-term cohort study. 192
Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study 192
Optimizing diagnostic approach to drug-induced liver injury 190
Association between reduced lymphocyte beta-adrenergic receptors and left ventricular dysfunction in young obese subjects 189
Cardiac involvement in patients with cirrhosis: a focus on clinical features and diagnosis 189
Fluoroquinolone-induced liver injury: three new cases and a review of the literature. 188
A focus on epidemiology of drug-induced liver injury: analysis of a prospective cohort 188
A questionable diagnosis in a woman with drowsiness 188
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 188
Left ventricular filling abnormalities and obesity-associated hypertension: relationship with overproduction of circulating transforming growth factor beta1. 186
Weight-loss supplementation and acute liver failure: the case of Garcinia Cambogia 185
Real life data on elbasvir/grazoprevir efficacy, safety and drug-drug interaction profile in patients with chronic hepatitis C viral infection: a prospective analysis in the PITER cohort 185
Liver and statins: a critical appraisal of the evidence 183
Patologie da sovraccarico di ferro:recenti acquisizioni 182
The presence of White Matter Lesions is not associated with Non-alcoholic Fatty Liver Disease but with its histological severity 182
Herbal hepatotoxicity: a hidden epidemic 182
Totale 23.711
Salva come PNG Salva come JPEG
Categoria #
all - tutte 124.460
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 124.460
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.193 0 449 80 100 87 109 131 165 284 261 177 350
2022/20233.256 277 599 47 332 273 455 228 444 335 52 130 84
2023/20241.552 68 178 81 113 118 337 153 98 73 87 74 172
2024/20253.634 113 237 181 304 156 134 234 220 289 443 531 792
2025/202613.457 812 341 679 1.071 1.291 1.966 1.950 1.413 1.237 1.407 678 612
2026/2027805 716 89 0 0 0 0 0 0 0 0 0 0
Totale 36.492